Benefits of Epoetin Alfa in Anemic Breast Cancer Patients Receiving Chemotherapy
- 1 April 2002
- journal article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 3 (1), 45-51
- https://doi.org/10.3816/cbc.2002.n.011
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly DosingJournal of Clinical Oncology, 2001
- Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue CoalitionThe Oncologist, 2000
- Fatigue in women treated with bone marrow transplantation for breast cancer: A comparison with women with no history of cancerSupportive Care in Cancer, 1997
- Fatigue in cancer patients: a review of the literatureEuropean Journal of Cancer Care, 1995
- Fatigue in cancer patientsBritish Journal of Cancer, 1993
- Quality of Life in Cancer: Definition, Purpose, and Method of MeasurementCancer Investigation, 1993
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Clinical applications of visual analogue scales: a critical reviewPsychological Medicine, 1988
- Assessment of the quality of life of patients with advanced cancerEuropean Journal of Cancer and Clinical Oncology, 1983
- Sensitivity and accuracy of the visual analogue scale: a psycho‐ physical classroom experiment.British Journal of Clinical Pharmacology, 1978